ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

SNG Synairgen Plc

4.675
0.155 (3.43%)
25 Jul 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Synairgen Plc LSE:SNG London Ordinary Share GB00B0381Z20 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.155 3.43% 4.675 4.35 5.00 - 25,623 16:35:16
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 0 -17.65M -0.0876 -0.52 9.1M
Synairgen Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker SNG. The last closing price for Synairgen was 4.52p. Over the last year, Synairgen shares have traded in a share price range of 3.65p to 10.62p.

Synairgen currently has 201,374,975 shares in issue. The market capitalisation of Synairgen is £9.10 million. Synairgen has a price to earnings ratio (PE ratio) of -0.52.

Synairgen Share Discussion Threads

Showing 4976 to 4998 of 99175 messages
Chat Pages: Latest  211  210  209  208  207  206  205  204  203  202  201  200  Older
DateSubjectAuthorDiscuss
24/4/2020
09:17
Please share?
slinkyj
24/4/2020
09:10
Sell thus stock tuday. Bad ting hapen 10.50
akbar1
24/4/2020
09:09
In Wikki UK biotech firm Synairgen started conducting trials on IFN-?, a drug that was originally developed to treat COPD.[10] IFN-? will be included in the international Solidarity Trial in combination with the HIV drugs Lopinavir and Ritonavir.[30]
slinkyj
24/4/2020
08:53
Bit of coverage in this is money https://www.thisismoney.co.uk/money/investinghub/share-tips-fund-tips.html
slinkyj
24/4/2020
08:50
A trade of 81p went through. Probably a fat finger or wrong ticker. It happens
vitec
24/4/2020
08:48
Hmm I just had an alert come through saying SNG broke 77? Did it spike this morning, have I missed something?
slinkyj
24/4/2020
08:43
Just need some more institutions buying up these shares and a 10p spread,that will sort the day traders out!
2nell
24/4/2020
08:41
Nobby perhaps they dont have your average and deep pockets.
chinadog3
24/4/2020
08:31
Real two way pull this morning. It is beyond me why people think 64p is a good price to sell at. Hey ho each to their own....
nobbygnome
24/4/2020
08:27
Yes, strange.
grosstonnage
24/4/2020
08:22
81p?? Anyone else just see that?
likya123
24/4/2020
08:20
If they keep the spread wide, it should make sellers hesitant 😉
makendon
24/4/2020
08:16
The potential to reach millions worldwide for asthma and copd let alone covid...i like this.
p winky
24/4/2020
08:11
From lse board..


People need to read the research undertaken by the University of Texas (put on this website by Jack). Interferon 1 much more effective against SARS COV2 than its predecessor SARS, due to difference in protein structure.

likya123
24/4/2020
08:09
Nobby, imagine what it will do when we're global news?!

Word is spreading.

likya123
24/4/2020
08:08
Encouraging start this morning....
nobbygnome
24/4/2020
08:04
Toffee man yes I am interested in that, because my mum wouldn't want to go in hospital but she would be fine to use a nebuliser because she is used to them. 4872
hazl
24/4/2020
07:56
A must watch from yesterday if you haven't already seen. We are still a little under the radar but not for very much longer...
likya123
24/4/2020
07:51
From what I hear there is little danger that the vaccine trial will be speedy. Because of the danger of the virus, the participants will not be exposed to live virus on purpose but be allowed to pick up any virus naturally. So if lockdown continues and virus spread is maintained at less than 1, then it will be a slow process.
glennrcharles
24/4/2020
07:51
That's looks like good news,but a small selection of patients, sng treatment will be earlier in the phase of the illness and should stop patients getting to the stage where that treatment is going to be needed hopefully
d1nga
24/4/2020
07:48
This has already been discussed.


SNG's Inhaled Intrferon B is to prevent the patient having to be put on a ventilator in the first place.

Better that they don't deteriorate to ventilator stage by intervention with SNG's treatment first, which would remove the need for treatment afterward and remove the need for a ventilator completely.

jev1
24/4/2020
07:41
Forget Gilead...now MESOBLAST +38%

its allogeneic cell therapy remestemcel-L was administered under emergency compassionate use to 12 ventilator-dependent patients at New York's Mount Sinai hospital in March and April. It reported an 83% survival rate in the patients compared with 12% in ventilator-dependent Covid-19 patients who didn't receive the treatment at two major referral hospital networks in New York during the same period.
The company said nine of the 12 patients, who received two infusions of remestemcel-L within the first five days of emergency treatment, came off ventilator support within a median of 10 days. That compared with 9% of patients receiving standard treatment.

markinvestor
24/4/2020
01:20
I am too a responder....being told to stay at home and run meetings on Webex is not my thing. :-)..although the meetings continue.
dovey21
Chat Pages: Latest  211  210  209  208  207  206  205  204  203  202  201  200  Older

Your Recent History

Delayed Upgrade Clock